Acquiring funding for this kind of research is a problem—the stigmatization of psilocybin has prompted governmental funding bodies to avoid initiatives involving the compound. Even so, Nichols thinks that, as trials demonstrating the potential benefits of psilocybin keep coming out, there may be a larger drive and incentive for expense. https://dantepchqc.blog5.net/72709869/getting-my-copyright-mushrooms-california-to-work